GlassScriptPhysician profile
Haley Follbaum
NPI 1134817828
$2,808.70
in general payments reported to CMS, 2019-2025
21 companies · $2,511 in 2025
The $2,511 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $298 · 2025: $2,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,658 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,657.76 |
| Education | $150.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $474.18 | 2025 | Tremfya, Stelara, Simponi Aria |
| Ucb, INC. | $441.78 | 2024-2025 | Bimzelx |
| Madrigal Pharmaceuticals | $430.14 | 2025 | Rezdiffra |
| Abbvie INC. | $418.24 | 2024-2025 | |
| Amgen INC. | $162.18 | 2024-2025 | Otezla, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.99 | 2025 | Xifaxan |
| Ardelyx, INC. | $139.11 | 2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $99.58 | 2025 | Eohilia, Entyvio |
| Sun Pharmaceutical Industries INC. | $69.73 | 2024-2025 | |
| Gilead Sciences, INC. | $69.68 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $62.37 | 2024-2025 | Sotyktu |
| Organon LLC | $57.63 | 2025 | Vtama |
| Novo Nordisk INC | $48.41 | 2025 | Wegovy |
| Botanix Sb INC | $38.52 | 2025 | Sofdra |
| Ipsen Biopharmaceuticals, INC | $32.84 | 2025 | Iqirvo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $20.36 | 2025 | Anzupgo |
| Novartis Pharmaceuticals Corporation | $19.82 | 2025 | |
| Aimmune Therapeutics, INC. | $19.75 | 2025 | Zenpep |
| Galderma Laboratories, L.P. | $19.64 | 2025 | Nemluvio |
| Journey Medical Corporation | $19.07 | 2024 | |
| Mayne Pharma Commercial LLC | $16.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Follbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.